Simcere Pharmaceutical Group Limited
SMHGF
$0.6486
-$0.0621-8.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.71% | -108.98% | -133.63% | -107.29% | -15.93% |
| Total Depreciation and Amortization | 1.49% | 0.48% | -1.72% | 0.67% | 3.22% |
| Total Amortization of Deferred Charges | 102.31% | 105.81% | 107.87% | 55.03% | 13.08% |
| Total Other Non-Cash Items | 736.88% | 202.92% | 191.46% | 192.20% | -163.36% |
| Change in Net Operating Assets | 90.64% | -20.32% | -1,214.76% | -1,214.76% | -1,214.76% |
| Cash from Operations | 848.25% | 236.42% | 80.52% | -39.04% | -89.90% |
| Capital Expenditure | 25.55% | -1.59% | -35.90% | -35.90% | -35.90% |
| Sale of Property, Plant, and Equipment | -57.34% | 42.81% | 41,743.48% | 41,743.48% | 41,743.48% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -96.68% | -95.82% | -94.93% | 7.67% | -- |
| Other Investing Activities | -263.70% | -239.28% | -205.00% | -85.18% | 2.45% |
| Cash from Investing | -192.01% | -181.30% | -169.09% | -57.33% | 937.42% |
| Total Debt Issued | 3.04% | 29.14% | 61.28% | 47.46% | 32.59% |
| Total Debt Repaid | -10.10% | -9.29% | -8.54% | -9.59% | -10.83% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -138.00% | -293.30% | -1,208.93% | -1,798.50% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 3.49% | -1.06% | -3.30% | -3.30% | -3.30% |
| Other Financing Activities | 2,733.60% | 2,740.30% | 2,747.09% | 1,199.44% | 22.90% |
| Cash from Financing | 55.05% | 71.57% | 87.48% | 42.27% | -13.82% |
| Foreign Exchange rate Adjustments | -53.64% | -78.10% | -85.64% | -77.54% | -68.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.75% | -76.00% | -49.01% | -50.14% | -50.81% |